Publications
Delaveris CS, Loudermilk RP, Pandey A, Remesh SG, Peters-Clarke TM, Ganjave SD, Dougherty WJN, Delavan HM, Wang C, Ling J, Camara Serrano JA, Salangsang F, Ding CC, Greenland N, Chu CE, Porten S, Steri V, Chou J, Evans MJ, Leung KK, Wells JA. Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer. Science (New York, N.Y.). 2026. PMID: 41818370
Vijayaraghavan M, Williams A, Bonniot C, Cheng C, Clark B, Safier J, Satterfield J, Pamatmat M, Schroeder SA. State Leadership Academies to Reduce Tobacco Use Prevalence in the United States: Four Case Studies of Early State Adopters of Tobacco Treatment and Policy. Public health reports (Washington, D.C. : 1974). 2026. PMID: 41797633
Nadine Goldhammer, Marin Bont, Shruti Warhadpande, Michael Choi, Jose Cedano, Heather Greenwood, Julia Ye, Christopher Schwartz, Michael Alvarado, Cheryl Ewing, Karen Goodwin, Rita Mukhtar, Jasmine Wong, Shoko Abe, Julia Chandler, Jordan Jackson, Olufunmilayo Olopade, Michael Campbell, Allison Lam, Chaelee Park, Anna Vertido, Laura van 't Veer, Nola Hylton, Laura Esserman, Jennifer Rosenbluth. Hormone signaling and immune programs define differential endocrine responsiveness in high-risk breast tissue bioRxiv. 2026. PMID:
Wan J, Saatcioglu HD, Ellis H, Aguado-Fraile E, Xu Q, Kondo H, Manguso RT, Gritti I, Norden BL, Noble C, Corcoran RB, Lubner SJ, Javle M, Abou-Alfa GK, Cleary JM, Kelley RK, Borad MJ, Macarulla T, Oh DY, Daigle S, Gliser C, Pandya S, Choe S, Tron AE, Bardeesy N. MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41460204
Chan SL, Yau T, Kelley RK, Finn RS, Yoo C, Furuse J, Ren Z, Klümpen HJ, Ozaka M, Pelzer U, Arslan C, Park JO, Edeline J, Valle JW, Ueno M, Vogel A, Starkopf L, Malhotra U, Siegel AB, Qin S. Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study. Cancer Research Communications. 2026. PMID: 41757470
Correia N, Johnson K, Durr M, Grimes BA, Lazar AA, Sarkar U, Ha PK, Chen L, Wai KC, Likhterov I, Yom SS, Chan JW, Algazi AP, Kang H, Ryan WR, Heaton CM, El-Sayed I, George J, Xu MJ. Timely Matters: Predictors of Delay in Oral Cavity Cancer Patients Across the Care Continuum. Laryngoscope investigative otolaryngology. 2026. PMID: 41767548
Kumar J, Jensen A, Lu R, Khanna V, Stehr H, Spinner M, Fernandez-Pol S, Greenberg PL, Tan B. Morphologic findings and mutational profiles of myelodysplastic neoplasms with normal versus abnormal karyotype. Journal of hematopathology. 2026. PMID: 41721060
Kelley RK, Lee Y, Conway J, Kurland JF, McCoon P. T-Cell Receptor and Immune Gene Expression Pharmacodynamics for Durvalumab Alone and with Tremelimumab or Bevacizumab in Unresectable Hepatocellular Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41359405
Kodali PB, Pednekar MS, Gupta PC, Quah ACK, Fong G?, Bialous SA, Vijayaraghavan M. Cessation outcomes and healthcare provider advice to quit among tobacco users: A cross-sectional analysis of the 2018-2019 Tobacco Control Policy (TCP) India survey. Tobacco induced diseases. 2026. PMID: 41716892
Zhu X, Alvarez EA, Umetsu SE, Chapman JS, Chen LM, Ueda S, Henderson S, Nguyen P, Calabrese S, Russell J, Aguilar J, Smith SA, Shah N, Feeney L, Van Ziffle J, Turski ML, Ko AH, Munster PN, Ashworth A, Collisson EA, Aggarwal RR. Efficacy of the ATR inhibitor ceralasertib in patients with ARID1A-deficient gynecologic and other solid tumor malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41686845
Zhu X, Alvarez EA, Umetsu SE, Chapman JS, Chen LM, Ueda S, Henderson S, Nguyen P, Calabrese S, Russell J, Aguilar J, Smith SA, Shah N, Feeney L, Van Ziffle J, Turski ML, Ko AH, Munster PN, Ashworth A, Collisson EA, Aggarwal RR. Efficacy of the ATR inhibitor ceralasertib in patients with ARID1A-deficient gynecologic and other solid tumor malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41686845
Spinner MA, Advani RH. Management of Classic Hodgkin Lymphoma in Pregnancy. Hematology/oncology clinics of North America. 2026. PMID: 41654459
Srinagesh HK, Gupta VK, Zhang A, Grunwald MR, Connor MP, Kota VK, Boccucci J, Ulrickson ML, Pradeep R, Hill LC, Tsai SB, O'Connor TE, Sandhu KS, Advani AS, Reshef R, Gordillo CA, Luskin MR, Chen EC, Lin C, Cassaday RD, Kopmar NE, Majhail NS, Battiwalla M, Strickland SA, Lee CJ, Odstrcil Bobillo S, Hilal T, Park JH, Valtis YK, Faramand RG, Solh MM, Guzowski C, Vasu S, Leonard JT, Tan V, Wang ES, McCauley R, Sasine JP, Tang K, Miller K, Sutherland KC, Daunov M, Mohty R, Jamy O, Kumaran M, Hoeg RT, Dykes KC, Logan AC, Othman T, Stock WA, Schwartz MS, Byrd K, Yalniz FF, Bachanova V, Tracy SI, Yaghmour G, Irizarry Gatell V, Jackson C, Oluwole OO, Dholaria B, O'Dwyer KM, Moore J, Roloff GW, Frey NV, Aldoss I, Shah BD, Oliai C, Muffly LS. Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene. Blood. 2026. PMID: 41643192
Srinagesh HK, Gupta VK, Zhang A, Grunwald MR, Connor MP, Kota VK, Boccucci J, Ulrickson ML, Pradeep R, Hill LC, Tsai SB, O'Connor TE, Sandhu KS, Advani AS, Reshef R, Gordillo CA, Luskin MR, Chen EC, Lin C, Cassaday RD, Kopmar NE, Majhail NS, Battiwalla M, Strickland SA, Lee CJ, Odstrcil Bobillo S, Hilal T, Park JH, Valtis YK, Faramand RG, Solh MM, Guzowski C, Vasu S, Leonard JT, Tan V, Wang ES, McCauley R, Sasine JP, Tang K, Miller K, Sutherland KC, Daunov M, Mohty R, Jamy O, Kumaran M, Hoeg RT, Dykes KC, Logan AC, Othman T, Stock WA, Schwartz MS, Byrd K, Yalniz FF, Bachanova V, Tracy SI, Yaghmour G, Irizarry Gatell V, Jackson C, Oluwole OO, Dholaria B, O'Dwyer KM, Moore J, Roloff GW, Frey NV, Aldoss I, Shah BD, Oliai C, Muffly LS. Blinatumomab Nonresponse Correlates with Poor Survival After Brexucabtagene. Blood. 2026. PMID: 41643192
Han Y, Byun J, VanLith CJ, Cooley MA, Shaw VR, Hatia RI, Ahmed FY, Giama NH, Ali HM, Campbell NA, Hassan M, Andersen JB, Ankoma-Sey V, Banales JM, Bujanda L, Bathe OF, Bekaii-Saab TS, Borad MJ, Björkström NK, Chan CHF, Cleary SP, Cornillet M, Folseraas T, Galle PR, Genkinger JM, MacInnis RJ, Gores GJ, Goyal L, Houlston RS, Ilyas SI, Javle M, Johansen JS, Christensen TD, Kamath AS, Kelley RK, Khan SA, Kim RD, Kwee SA, Lamarca A, Lammert F, LaRusso NF, Lindsey S, Macias RIR, Malhi H, Patel TC, Permuth JB, Reeves HL, Rossi S, Sanchez W, Smoot RL, Swerdlow AJ, Tran Cao HS, Valle JW, Weinmann A, Weinmann-Menke J, Wong LL, Zhang X, Zimmer V, Zhu AX, Lazaridis KN, Juran BD, Jalal P, Knox JJ, Hutchinson A, Hicks B, Koshiol JE, Chanock SJ, Hassan MM, Amos CI, McGlynn KA, Roberts LR. Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses. Hepatology (Baltimore, Md.). 2026. PMID: 41627892
Advani RH, Kelsey CR, Armand P, Bello CM, Benitez CM, Bond D, Chen W, Cherian S, Czader M, Dabaja B, Daly ME, Frosch Z, Gordon LI, Hansen N, Herrera AF, Hochberg EP, Hoppe RT, Isufi I, Johnston PB, Kelly K, Kenkre VP, Kline J, Lynch RC, McConathy J, Morgan D, Niu A, Paul S, Rabinovitch R, Salavati A, Sano D, Shah H, Spinner M, Svoboda J, Winter JN, Yahalom J, Yang JC, Montgomery S, Stehman K. Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41671432
Ma S, Spinner MA. Optimizing the Role of Checkpoint Inhibitors in the Management of Hodgkin Lymphoma. Journal of the National Comprehensive Cancer Network : JNCCN. 2026. PMID: 41698326
O'Reilly EM, Cabanski CR, Lyman JP, Wainberg ZA, Fisher GA, Wolff RA, Ko AH, O'Hara MH, Spencer CN, Yu JX, Da Silva DM, Padrón LJ, Arnott J, Fairchild J, Moore JS, Peng B, Hoos WA, O'Donnell-Tormey J, Boffo S, Dugan U, Kimmelman AC, Amaravadi RK, Vonderheide RH. Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma. Journal for immunotherapy of cancer. 2026. PMID: 41617393
Luck C, Luo Y, Vasileva E, Jacobs KA, Riad J, Macaraig CD, Ponce RKM, Amatruda JF, Okimoto RA. Modeling of Capicua Family Fusion Oncoprotein-Driven Cancers Reveals Gene-Specific Functionality. Molecular cancer research : MCR. 2026. PMID: 41575738
Bidkar AP, Bidlingmaier S, Wadhwa A, Mayne E, Raveendran A, Naik S, Xue C, Basak M, Bobba KN, Patiño-Escobar B, Greenland N, Camara Serrano JA, Steri V, Chou J, Wiita A, He J, Wilson DM, Aggarwal R, VanBrocklin HF, Seo Y, Liu B, Flavell RR. Synergistic treatment of prostate cancer and multiple myeloma using CD46-targeted radioimmunotherapy-antibody drug conjugates. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026. PMID: 41569419